Loree Larratt Selected Research

Loree Larratt Research Topics

Disease

7	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 04/2010
6	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2016 - 03/2007
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2016 - 04/2006
4	Leukemia 05/2016 - 04/2006
2	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 07/2023 - 11/2020
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 09/2020
2	Neoplasms (Cancer) 01/2018 - 01/2013
1	Fatigue 07/2023
1	Hemolysis 07/2023
1	Abdominal Pain (Pain, Abdominal) 07/2023
1	Hypertension (High Blood Pressure) 01/2022
1	Disease Progression 01/2022
1	Residual Neoplasm 01/2022
1	Bone Marrow Diseases (Bone Marrow Disease) 11/2020
1	Vertigo (Positional Vertigo) 09/2020
1	Atrial Fibrillation 09/2020
1	Chest Pain (Chest Pains) 09/2020
1	Hemorrhage 09/2020
1	Pancreatitis 09/2020
1	Pulmonary Embolism 09/2020
1	Thrombosis (Thrombus) 09/2020
1	Bone Marrow Failure Disorders 07/2020
1	Neuroendocrine Carcinoma 01/2019
1	Sudden Death 01/2019
1	Atypical Hemolytic Uremic Syndrome 01/2018
1	Hairy Cell Leukemia 01/2018
1	Thrombotic Thrombocytopenic Purpura 01/2018
1	Heart Diseases (Heart Disease) 11/2016
1	Virus Diseases (Viral Diseases) 01/2016
1	Infections 01/2016
1	Hematologic Neoplasms (Hematological Malignancy) 09/2013
1	Cardiomyopathies (Cardiomyopathy) 01/2013
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2010
1	Lymphoma (Lymphomas) 01/2007
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2007

Drug/Important Bio-Agent (IBA)

6	fludarabineIBA 11/2016 - 07/2007
4	Rituximab (Mabthera)FDA Link 01/2018 - 04/2010
4	thymoglobulin FDA Link 05/2016 - 07/2007
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2016 - 07/2007
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2016 - 04/2010
3	TESIBA 07/2023 - 07/2020
3	Chlorambucil (Leukeran)FDA Link 01/2022 - 01/2019
3	obinutuzumabIBA 01/2022 - 01/2019
3	ibrutinibIBA 01/2022 - 01/2019
3	Methotrexate (Mexate)FDA LinkGeneric 05/2016 - 07/2007
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 09/2013 - 03/2007
2	Complement System Proteins (Complement)IBA 07/2023 - 05/2016
2	eltrombopag FDA Link 01/2022 - 09/2020
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 09/2020
2	eculizumab FDA Link 11/2020 - 01/2018
2	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2016 - 04/2006
2	Monoclonal AntibodiesIBA 11/2010 - 04/2010
2	Busulfan (Busulfex)FDA Link 04/2010 - 07/2007
1	Proteins (Proteins, Gene)FDA Link 07/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2023
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 07/2023
1	Inosine Triphosphate (ITP)IBA 01/2022
1	immunotoxin HA22IBA 01/2018
1	SteroidsIBA 01/2018
1	Immunotoxins (Immunotoxin)IBA 01/2018
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2016
1	AnthracyclinesIBA 11/2016
1	Prednisone (Sone)FDA LinkGeneric 02/2016
1	Immunoglobulin A (IgA)IBA 01/2016
1	adhesion receptorIBA 11/2014
1	Surface Antigens (Surface Antigen)IBA 04/2010
1	Mitoxantrone (Novantrone)FDA LinkGeneric 04/2006
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 04/2006
1	Etoposide (VP 16)FDA LinkGeneric 04/2006

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2019 - 04/2006
4	Therapeutics 01/2022 - 09/2013
2	Cell Transplantation 05/2016 - 01/2016
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 03/2007 - 01/2007
1	Splenectomy 09/2020
1	Minor Surgical Procedures (Minor Surgery) 09/2020
1	Plasmapheresis 01/2018
1	Hematopoietic Stem Cell Transplantation 04/2010
1	Stem Cell Transplantation 07/2007
1	Homologous Transplantation 07/2007
1	Transplantation 03/2007